follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      Home2018January

      Month: January 2018

      Drug Manufacturers

      Sorrento Therapeutics Higher on Bullish Reports

      Jan 22 Siraj Sarwar
      Sorrento Therapeutics (NASDAQ:SRNE) shares are rallying over the last three months, thanks to the company’s smart business strategies and advancements in its pipeline. Its shares spiked more than 20% in Monday trade and its volume ... [Read]
      StarTek
      Business Services

      Is StarTek Ready to Bounce Back?

      Jan 22 Siraj Sarwar
      After hitting the highest level of $14.78 per share in the mid of the last year, StarTek (NASDAQ:SRT) shares plunged in the second half, driven by lower than expected financial results. The $166 million company ... [Read]
      Biotechnology

      Idera Pharmaceuticals Stock Plunges 20% – Here’s Why

      Jan 22 Samara Malkin
      Idera Pharmaceuticals Inc. (NASDAQ:IDRA) is under investigation by Levi & Korsinsky, LLP, an established firm in securities litigation. What happened? Earlier in the day, it was announced that Idera Pharmaceuticals would be merging with BioCryst ... [Read]
      Business Services

      Lightbridge Corp Stock Flies Higher After Patent Approval

      Jan 22 Siraj Sarwar
      Lightbridge Corp (NASDAQ:LTBR) shares rallied as much as 90% in Monday’s trade after receiving approval for the key patent of the innovative fuel design. Before the latest rally, its shares were trading in a narrow ... [Read]
      Bullish Bets Soar on GNC Holdings
      Consumer

      Bullish Bets Soar on GNC Holdings After Earnings Guidance

      Jan 19 Siraj Sarwar
      After the massive rally of more than 46% in Thursday trade, GNC Holdings (NYSE:GNC) shares are down almost 9% in Friday trading. GNC stock currently trades just below $5 a share with a market capitalization of ... [Read]
      ThreeD Capital Up 32%
      Cryptocurrency

      ThreeD Capital Up 32% After Dropping Last Week

      Jan 19 Caroline Harris
      Everything that is happening to ThreeD Capital (CSE:IDK) (OTC:BWSOF) right now is a prime example of just how volatile the stock market can be. For the past two weeks, I have been keeping a relatively ... [Read]
      Higher Volume Supports Sientra Stock
      Health

      Analysts Upgrades and Higher Volume Supports Sientra Stock

      Jan 19 Siraj Sarwar
      Sientra, Inc. (NASDAQ:SIEN) stock price gained 16% during Friday trading, thanks to a strong growth in volume and higher price targets. Volumes are important for the stock, as stock price usually moves up with the ... [Read]
      Glance Technologies Thinks it Can Enter Market
      Cryptocurrency

      Glance Technologies Thinks it Can Enter Market as ‘The’ Cryptocurrency, So Why’s the Stock Dropping?

      Jan 19 Caroline Harris
      Cryptocurrency is huge. For the most part, it has proven to be quite beneficial – despite having a number of price crashes lately – so it’s no surprise that the corporate world is starting to ... [Read]
      Forward Industries Acquires Intelligent Product Solutions
      Consumer

      Forward Industries Acquires Intelligent Product Solutions, Stock Soars a Whopping 157%

      Jan 19 Caroline Harris
      Forward Industries (NASDAQ:FORD) is still reaping the benefits of the announcement it disclosed to the public on Thursday. In fact, investors seem to be so pleased with the Pompano Beach, Florida-based company that the stock ... [Read]
      Acorda Therapeutics as a Potential Takeover Target
      Biotechnology

      Are Companies Looking at Acorda Therapeutics as a Potential Takeover Target?

      Jan 19 Caroline Harris
      Two months ago, New York-based Acorda Therapeutics (NASDAQ:ACOR) had to discard its late-stage drug tozadenant due to five patients passing away in a clinical trial. At the time, this looked like it was going to ... [Read]

      Posts pagination

      « 1 … 6 7 8 … 20 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Subscribe & Get FREE Sorrento Therapeutics Inc. Email Alerts
      Get FREE Sorrento Therapeutics Inc. Email Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      x